The Use of Antiviral Drugs for Influenza: Guidance for Practitioners 2012/2013

Simple item page
dc.contributor.authorAoki, Fred Y
dc.contributor.authorAllen, Upton D
dc.contributor.authorStiver, H Grant
dc.contributor.authorEvans, Gerald A
dc.date.accessioned2016-06-07T19:17:31Z
dc.date.available2016-06-07T19:17:31Z
dc.date.issued2012-1-1
dc.date.updated2016-06-07T06:54:27Z
dc.description.abstractThe present article addresses the use of antiviral drugs in the management of seasonal influenza illness for the 2012/2013 season. It updates the previous document published in 2011 (1). Noteworthy guidance updates since 2011 include the following: Seasonal influenza in 2012/2013 is predicted to be caused by two human influenza A and one influenza B strain, all of which are anticipated to remain generally susceptible to oseltamivir.The predicted strains are A/California/7/2009 (H1N1) pdm09-like, A/Victoria/361/2011 (H3N2)-like and B/Wisconsin/1/2010-like (Yamagata lineage). All are included in the seasonal influenza vaccine and are susceptible to oseltamivir.Swine-variant H3N2v, which has rarely caused infection in humans exposed to infected swine within the past year in the United States, is susceptible to oseltamivir. It is not included in the current seasonal influenza vaccine.It is still considered that initiation of antiviral therapy more than 36 h to 48 h after onset of symptoms is beneficial in patients hospitalized with complicated influenza and severe illness.Oseltamivir continues to be recommended for the treatment of influenza in pregnant women.The use of antiviral drugs among measures to control outbreaks of influenza in closed facilities such as correctional institutions is now included in the present document.
dc.description.versionPeer Reviewed
dc.identifier.citationFred Y Aoki, Upton D Allen, H Grant Stiver, and Gerald A Evans, “The Use of Antiviral Drugs for Influenza: Guidance for Practitioners 2012/2013,” Canadian Journal of Infectious Diseases and Medical Microbiology, vol. 23, no. 4, pp. e79-e92, 2012. doi:10.1155/2012/879141
dc.identifier.urihttp://dx.doi.org/10.1155/2012/879141
dc.identifier.urihttp://hdl.handle.net/1993/31352
dc.language.rfc3066en
dc.rightsopen accessen_US
dc.rights.holderCopyright © 2012 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleThe Use of Antiviral Drugs for Influenza: Guidance for Practitioners 2012/2013
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
CJIDMM.2012.879141.xml
Size:
16.9 KB
Format:
Extensible Markup Language
Description:
Download
Thumbnail Image
Name:
CJIDMM.2012.879141.pdf
Size:
772.09 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.24 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
University of Manitoba Scholarship
Rady Faculty of Health Sciences Scholarly Works